Showing results (1-10 of 784) with videos related to
Sort By:
Pageof 79
Anti-Cancer Drugs|January 1, 1996
Octreotide therapy in carcinoid diseaseN D Bax, H F Woods, A Batchelor, et al.World Journal of Surgery|February 1, 1996
Clinical manifestations of carcinoid diseaseN D Bax, H F Woods, A Batchelor, et al.British Journal of Clinical Pharmacology|October 1, 1980
Lignocaine and indocyanine green kinetics in patients following myocardial infarctionN D Bax, G T Tucker, H F WoodsBritish Journal of Clinical Pharmacology|May 1, 1985
The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibitionN D Bax, G T Tucker, M S Lennard, et al.Biochemical Pharmacology|July 15, 1987
Irreversible binding and metabolism of propranolol by human liver microsomes--relationship to polymorphic oxidationL Shaw, M S Lennard, G T Tucker, et al.British Journal of Clinical Pharmacology|May 1, 1985
Penbutolol and propranolol: a comparison of their effects on antipyrine clearance in manN D Bax, R W Jones, M S Lennard, et al.British Journal of Clinical Pharmacology|January 1, 1984
Effects of beta-adrenoceptor antagonists on the pharmacokinetics of lignocaineG T Tucker, N D Bax, M S Lennard, et al.British Journal of Clinical Pharmacology|May 1, 1984
The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin after a single doseN D Bax, M S Lennard, G T Tucker, et al.Pageof 79